Stereotaxis, Inc.
STXS- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001289340
In the last 90 days, Stereotaxis, Inc. insiders filed 3 open-market purchases and 0 sales; 101 institutions reported holding it in 13F filings for Q3 2026, worth $50.4M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 17, 2026, 2:20 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $21.6M (66.8% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 9, 2026 | Mar 3, 2025 | Mar 4, 2024 | Mar 3, 2023 | Mar 3, 2022 |
| Revenue | $32.4M | $26.9M | $26.8M | $28.1M | $35.0M |
| Cost of revenue | $15.3M | $12.3M | $11.9M | $9.68M | $11.8M |
| Gross profit | $17.1M | $14.6M | $14.9M | $18.5M | $23.2M |
| Operating expenses | $39.2M | $39.3M | $36.7M | $37.2M | $36.1M |
| Research and development | $9.38M | $9.76M | $10.3M | $10.6M | $10.2M |
| Selling, general and administrative | $17.8M | $17.2M | $14.1M | $14.4M | $14.0M |
| Operating income | -$22.1M | -$24.7M | -$21.8M | -$18.8M | -$12.9M |
| Net income | -$21.6M | -$24.0M | -$20.7M | -$18.3M | -$10.7M |
| EPS, basic | $-0.25 | $-0.30 | $-0.27 | $-0.26 | $-0.16 |
| EPS, diluted | $-0.25 | $-0.30 | $-0.27 | $-0.26 | $-0.16 |
| Weighted shares, basic | 91.0M | 85.2M | 80.7M | 76.1M | 75.6M |
| Weighted shares, diluted | 91.0M | 85.2M | 80.7M | 76.1M | 75.6M |
| Margins and growth | |||||
| Gross margin | 52.7% | 54.2% | 55.5% | 65.6% | 66.3% |
| Operating margin | -68.3% | -91.9% | -81.6% | -66.7% | -36.8% |
| Net margin | -66.8% | -89.3% | -77.4% | -65.0% | -30.6% |
| Revenue growth, year over year | +20.3% | +0.5% | −4.9% | −19.6% | +31.5% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025! | FY2024! | FY2023! | FY2022! | FY2021! |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 9, 2026 | Mar 3, 2025 | Mar 4, 2024 | Mar 3, 2023 | Mar 3, 2022 |
| Cash and equivalents | $13.4M | $12.2M | $19.8M | $8.59M | $38.7M |
| Short-term investments | – | – | – | $19.8M | – |
| Accounts receivable | $5.85M | $3.82M | $3.82M | $5.09M | $5.41M |
| Inventory | $9.57M | $8.33M | $8.43M | $7.88M | $4.43M |
| Total current assets | $33.8M | $26.4M | $33.3M | $43.2M | $51.4M |
| Property, plant and equipment | $3.02M | $3.57M | $3.30M | $3.83M | $2.63M |
| Goodwill | $3.76M | $3.76M | – | – | – |
| Intangible assets | $6.43M | $7.36M | – | – | – |
| Total assets | $52.3M | $46.7M | $41.9M | $53.4M | $61.0M |
| Accounts payable | $4.77M | $5.67M | $3.19M | $3.27M | $4.19M |
| Total current liabilities | $22.4M | $21.6M | $13.2M | $14.3M | $13.3M |
| Total liabilities | $33.5M | $35.3M | $20.0M | $21.5M | $21.6M |
| Shareholders' equity | $13.5M | $6.08M | $16.3M | $26.3M | $33.8M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 9, 2026 | Mar 3, 2025 | Mar 4, 2024 | Mar 3, 2023 | Mar 3, 2022 |
| Operating cash flow | -$13.7M | -$8.50M | -$9.14M | -$8.41M | -$2.95M |
| Capital expenditures | $93.0K | $34.0K | $366.0K | $2.38M | $1.40M |
| Free cash flow | -$13.8M | -$8.53M | -$9.51M | -$10.8M | -$4.34M |
| Stock-based compensation | $9.85M | $10.3M | $10.6M | $10.6M | $9.36M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Investing cash flow | -$93.0K | $74.0K | $19.8M | -$22.1M | -$1.40M |
| Financing cash flow | $14.8M | $297.0K | $81.0K | $220.0K | $547.4K |
| Net change in cash | $985.0K | -$8.13M | $10.7M | -$30.3M | -$3.80M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 30.4% | 38.1% | 39.7% | 37.6% | 26.7% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 31, 2026 | 100.9M | +8.1% | SEC |
| Jul 31, 2026 | 100.2M | +10.5% | SEC |
| Apr 30, 2026 | 97.7M | +13.6% | SEC |
| Feb 28, 2026 | 97.2M | +13.1% | SEC |
| Oct 31, 2025 | 93.3M | +10.1% | SEC |
| Jul 31, 2025 | 90.7M | +7.1% | SEC |
| Apr 30, 2025 | 86.0M | +4.1% | SEC |
| Feb 28, 2025 | 86.0M | +4.7% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.